European efforts to harmonize typing of meningococci

International Journal of Medical Microbiology

Volumn 301, Issue 8, 2011, Pages 659-662

  Vogel, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Epidemiology; Harmonization; Laboratory surveillance; Meningococcal disease; Neisseria meningitidis; Typing

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; BEXSERO; MENINGOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN EXPRESSION; BACTERIAL GENOME; BACTERIAL INFECTION; CHILD; CLINICAL LABORATORY; DNA SEQUENCE; EUROPE; HUMAN; INFANT; MENINGOCOCCOSIS; MONITORING; NEISSERIA MENINGITIDIS; NONHUMAN; PRESCHOOL CHILD; REFERENCE DATABASE; SCHOOL CHILD; SCREENING; SHORT SURVEY; STANDARDIZATION;

ADOLESCENT; EUROPE; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; MENINGOCOCCAL INFECTIONS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NEISSERIA MENINGITIDIS;

EID: 80555131035     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2011.09.001     Document Type: Short Survey

References (32)

1. Aires-de-Sousa M., Boye K., de Lencastre H., Deplano A., Enright M.C., Etienne J., Friedrich A., Harmsen D., Holmes A., Huijsdens X.W., Kearns A.M., Mellmann A., Meugnier H., Rasheed J.K., Spalburg E., Strommenger B., Struelens M.J., Tenover F.C., Thomas J., Vogel U., Westh H., Xu J., Witte W. High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J. Clin. Microbiol. 2006, 44:619-621.
2. Amato-Gauci A., Ammon A. The surveillance of communicable diseases in the European Union - a long-term strategy (2008-2013). Euro Surveill. 2008, 13. pii: 18912.
3. Borrow R., Balmer P., Miller E. Meningococcal surrogates of protection - serum bactericidal antibody activity. Vaccine 2005, 23:2222-2227.
4. Buckee C.O., Jolley K.A., Recker M., Penman B., Kriz P., Gupta S., Maiden M.C. Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15082-15087.
5. Caugant D.A., Tzanakaki G., Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol. Rev. 2007, 31:52-63.
6. Donnelly J., Medini D., Boccadifuoco G., Biolchi A., Ward J., Frasch C., Moxon E.R., Stella M., Comanducci M., Bambini S., Muzzi A., Andrews W., Chen J., Santos G., Santini L., Boucher P., Serruto D., Pizza M., Rappuoli R., Giuliani M.M. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19490-19495.
7. Elias J., Harmsen D., Claus H., Hellenbrand W., Frosch M., Vogel U. Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg. Infect. Dis. 2006, 12:1689-1695.
8. Elias J., Schouls L.M., van de Pol I., Keijzers W.C., Martin D.R., Glennie A., Oster P., Frosch M., Vogel U., van der Ende A. Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany. Emerg. Infect. Dis. 2010, 16:465-472.
9. Fox A.J., Taha M.K., Vogel U. Standardized nonculture techniques recommended for European reference laboratories. FEMS Microbiol. Rev. 2007, 31:84-88.
10. Frasch C.E., Borrow R., Donnelly J. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine 2009, 27(Suppl. 2):B112-B116.
11. Grundmann H., Aanensen D.M., van den Wijngaard C.C., Spratt B.G., Harmsen D., Friedrich A.W. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med. 2010, 7:e1000215. European Staphylococcal Reference Laboratory Working Group.
12. Hoek M., Hanquet G., Heuberger S., Stefanoff P., Zucs P., Ramsay M., Stuart J. A European survey on public health policies for managing cases of meningococcal disease and their contacts. Euro Surveill. 2008, 13. pii: 8060.
13. Hoek M.R., Christensen H., Hellenbrand W., Stefanoff P., Howitz M., Stuart J.M. Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review. Epidemiol. Infect. 2008, 136:1441-1447.
14. Jolley K.A., Brehony C., Maiden M.C. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol. Rev. 2007, 31:89-96.
15. Jolley K.A., Maiden M.C. AgdbNet - antigen sequence database software for bacterial typing. BMC Bioinformatics 2006, 7:314.
16. Jolley K.A., Maiden M.C. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010, 11:595.
17. Maiden M.C., Ibarz-Pavon A.B., Urwin R., Gray S.J., Andrews N.J., Clarke S.C., Walker A.M., Evans M.R., Kroll J.S., Neal K.R., Ala'Aldeen D.A., Crook D.W., Cann K., Harrison S., Cunningham R., Baxter D., Kaczmarski E., Maclennan J., Cameron J.C., Stuart J.M. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 2008, 197:737-743.
18. Murphy E., Andrew L., Lee K.L., Dilts D.A., Nunez L., Fink P.S., Ambrose K., Borrow R., Findlow J., Taha M.K., Deghmane A.E., Kriz P., Musilek M., Kalmusova J., Caugant D.A., Alvestad T., Mayer L.W., Sacchi C.T., Wang X., Martin D., von G.A., du P.M., Klugman K.P., Anderson A.S., Jansen K.U., Zlotnick G.W., Hoiseth S.K. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J. Infect. Dis. 2009, 200:279-289.
19. Olcen P., Fredlund H. Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when?. Scand. J. Infect. Dis. 2010, 42:4-11.
20. Poolman J.T., Kriz-Kuzemenska P., Ashton F., Bibb W., Dankert J., Demina A., Froholm L.O., Hassan-King M., Jones D.M., Lind I., Prakash K., Xujing H. Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin. Diagn. Lab. Immunol. 1995, 2:69-72.
21. Reinhardt M., Elias J., Albert J., Frosch M., Harmsen D., Vogel U. EpiScanGIS: an online geographic surveillance system for meningococcal disease. Int. J. Health Geogr. 2008, 7:33.
22. Rosenstein N.E., Perkins B.A., Stephens D.S., Popovic T., Hughes J.M. Meningococcal disease. N. Engl. J. Med. 2001, 344:1378-1388.
23. Schoen C., Tettelin H., Parkhill J., Frosch M. Genome flexibility in Neisseria meningitidis. Vaccine 2009, 27(Suppl. 2):B103-B111.
24. Schrauder A., Claus H., Elias J., Vogel U., Haas W., Hellenbrand W. Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003. Epidemiol. Infect. 2007, 135:657-664.
25. Taha M.K., Alonso J.M., Cafferkey M., Caugant D.A., Clarke S.C., Diggle M.A., Fox A., Frosch M., Gray S.J., Guiver M., Heuberger S., Kalmusova J., Kesanopoulos K., Klem A.M., Kriz P., Marsh J., Molling P., Murphy K., Olcen P., Sanou O., Tzanakaki G., Vogel U. Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J. Clin. Microbiol. 2005, 43:144-149.
26. Taha M.K., Hedberg S.T., Szatanik M., Hong E., Ruckly C., Abad R., Bertrand S., Carion F., Claus H., Corso A., Enriquez R., Heuberger S., Hryniewicz W., Jolley K.A., Kriz P., Mollerach M., Musilek M., Neri A., Olcen P., Pana M., Skoczynska A., Sorhouet P.C., Stefanelli P., Tzanakaki G., Unemo M., Vazquez J.A., Vogel U., Wasko I. Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrob. Agents Chemother. 2010, 54:3651-3658.
27. Taha M.K., Vazquez J.A., Hong E., Bennett D.E., Bertrand S., Bukovski S., Cafferkey M.T., Carion F., Christensen J.J., Diggle M., Edwards G., Enriquez R., Fazio C., Frosch M., Heuberger S., Hoffmann S., Jolley K.A., Kadlubowski M., Kechrid A., Kesanopoulos K., Kriz P., Lambertsen L., Levenet I., Musilek M., Paragi M., Saguer A., Skoczynska A., Stefanelli P., Thulin S., Tzanakaki G., Unemo M., Vogel U., Zarantonelli M.L. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob. Agents Chemother. 2007, 51:2784-2792.
28. Tan L.K., Carlone G.M., Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med. 2010, 362:1511-1520.
29. Trotter C.L., Chandra M., Cano R., Larrauri A., Ramsay M.E., Brehony C., Jolley K.A., Maiden M.C., Heuberger S., Frosch M. A surveillance network for meningococcal disease in Europe. FEMS Microbiol. Rev. 2007, 31:27-36.
30. Vazquez J.A., Arreaza L., Block C., Ehrhard I., Gray S.J., Heuberger S., Hoffmann S., Kriz P., Nicolas P., Olcen P., Skoczynska A., Spanjaard L., Stefanelli P., Taha M.K., Tzanakaki G. Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrob. Agents Chemother. 2003, 47:3430-3434.
31. Vogel U. Molecular epidemiology of meningococci: application of DNA sequence typing. Int. J. Med. Microbiol. 2010, 300:415-420.
32. Vogel U., Claus H. Vaccine development against Neisseria meningitidis. Microb. Biotechnol. 2010, 4:20-31.